Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Celiac Disease Treatment Companies

ID: MRFR/HC/7002-HCR
110 Pages
Nidhi Mandole
Last Updated: February 16, 2025
Celiac Disease Treatment companies are dedicated to addressing the unique needs of individuals with celiac disease. Specializing in research and development, they offer innovative treatments and products that support gluten-free lifestyles, improving the management and well-being of those affected by this autoimmune condition.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Celiac Disease Treatment Market

Market Size

Forecast Period2025 - 2035
CAGR (2025 - 2035)11.03%
2024 Market Size$ 610.68 Million
2025 Market Size$ 678.05 Million
2035 Market Size$ 1,930.82 Million

Key Players

AbbVie
Gluten Free Holdings
General Mills
Kraft Heinz
Nestle
Pinnacle Foods
Opportunities
  • Market Growth Projections
  • Advancements in Treatment Options
  • Increased Awareness and Education

Top Industry Leaders in the Celiac Disease Treatment Market

Celiac Disease Treatment Key Companies
ย 
Latestย Celiac Disease Treatmentย Companies Update:

Chugai Pharmaceutical Published promising results from a non-clinical study on DONQ52, a medication targeting the immune response to gluten without affecting the whole immune system. A phase 1 clinical trial is ongoing.

Topas Therapeutics Their phase 2a clinical trial for TPM502, an antigen-specific nanoparticle therapy for celiac disease, is underway. This therapy aims to induce immune tolerance towards gluten.

Alnylam Pharmaceuticals Announced positive preliminary results from a phase 1b study of lumasiran for celiac disease. Lumasiran targets a specific gene involved in the immune response to gluten.

ImmusanT This clinical-stage biotech company is developing ITM-15, a potential first-in-class T-cell therapy for celiac disease. They announced the initiation of a phase 1b/2a clinical trial in December 2023.

List ofย Celiac Disease Treatmentย Key companies in the market
  • General Mills Inc.

  • Innovate Biopharmaceutical

  • ActoBio

  • Glenmark Pharmaceuticals Company Ltd.

  • Takeda Pharmaceuticals Company Ltd.

  • Zydus Pharmaceuticals Inc.

  • BioLineRx

  • West-Ward Pharmaceuticals Company Ltd.

  • Calypso Biotech SA